France vs Marshall Islands: Coverage of the human papillomavirus vaccine
France
51
in 2025
Marshall Islands
49
in 2025
France rank
62nd
Marshall Islands rank
64th
Coverage of the human papillomavirus vaccine over time
- France
- Marshall Islands
How they compare
France currently reports 51 against 49 in Marshall Islands, a difference of 2.
The two have swapped places 4 times across 13 shared years of data; in 2013 it was France ahead.
France ranks 62nd and Marshall Islands ranks 64th of 85 countries.
Across the 2 decades both report, France averaged higher in 1 and Marshall Islands in 1.
Head to head by decade
| Decade | France | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 22.14 | 21.43 | 0.7143 | France |
| 2020s | 44.67 | 49.5 | 4.83 | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher coverage of the human papillomavirus vaccine, France or Marshall Islands?
- France, at 51 against 49 in Marshall Islands as of 2025.
- What is the difference in coverage of the human papillomavirus vaccine between France and Marshall Islands?
- 2, with France ahead.
- How many years of comparable data are there for France and Marshall Islands?
- 13 years are reported by both, from 2013 to 2025.
- How do France and Marshall Islands rank globally for coverage of the human papillomavirus vaccine?
- France ranks 62nd and Marshall Islands ranks 64th of 85 countries.
- Where does this data come from?
- Our World in Data, published as Coverage of the human papillomavirus vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.